As of our 2025 comparison, Wegovy (semaglutide) and Zepbound (tirzepatide) are the brand names specifically FDA-approved for chronic weight management
However, an important shift is occurring Read More Oral GLP1 Therapy for Type 2 Diabetes: Why Pills Could Change the Playbook Jan 16, 2026 Articles, Blood Glucose Control, Diabetes, Obesity, Therapies, Top Articles, Type 2 Diabetes, Type 2 Diabetes 1,515 views The arrival of oral GLP1 therapy for type 2 diabetes marks a pivotal shift in diabetes care
If you have been offered B12 injections at a beauty salon, nail bar or non-medical clinic, it is worth asking what form of B12 they are administering and whether it is being prescribed by a qualified prescriber
& Pachitariu, M
Ozempic contains semaglutide as its active ingredient, which slows down the gastric emptying, leading to nausea and a feeling of fullness